AU3108200A - Methods to reduce variance in treatment studies using genotyping - Google Patents

Methods to reduce variance in treatment studies using genotyping

Info

Publication number
AU3108200A
AU3108200A AU31082/00A AU3108200A AU3108200A AU 3108200 A AU3108200 A AU 3108200A AU 31082/00 A AU31082/00 A AU 31082/00A AU 3108200 A AU3108200 A AU 3108200A AU 3108200 A AU3108200 A AU 3108200A
Authority
AU
Australia
Prior art keywords
genotyping
methods
treatment studies
reduce variance
variance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31082/00A
Inventor
Hywel B. Jones
Hugh Y. Rienhoff Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DNA Sciences Inc
Original Assignee
Kiva Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiva Genetics Inc filed Critical Kiva Genetics Inc
Publication of AU3108200A publication Critical patent/AU3108200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU31082/00A 1998-12-02 1999-12-01 Methods to reduce variance in treatment studies using genotyping Abandoned AU3108200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11066898P 1998-12-02 1998-12-02
US60110668 1998-12-02
PCT/US1999/028582 WO2000033161A2 (en) 1998-12-02 1999-12-01 Methods to reduce variance in treatment studies using genotyping

Publications (1)

Publication Number Publication Date
AU3108200A true AU3108200A (en) 2000-06-19

Family

ID=22334245

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31082/00A Abandoned AU3108200A (en) 1998-12-02 1999-12-01 Methods to reduce variance in treatment studies using genotyping

Country Status (6)

Country Link
EP (1) EP1155361A2 (en)
JP (1) JP2003501005A (en)
AU (1) AU3108200A (en)
CA (1) CA2350069A1 (en)
MX (1) MXPA01005513A (en)
WO (1) WO2000033161A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7058517B1 (en) 1999-06-25 2006-06-06 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US6931326B1 (en) 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
CN103710429B (en) 2005-11-29 2016-03-30 剑桥企业有限公司 Markers for breast cancer
EP2438193B1 (en) 2009-06-01 2015-07-22 Genetic Technologies Limited Methods for breast cancer risk assessment
JP5656159B2 (en) * 2009-08-24 2015-01-21 独立行政法人理化学研究所 Markers for predicting the effects of interferon therapy
JP6114584B2 (en) * 2013-03-14 2017-04-12 株式会社スタージェン Method for determining standard values for measurement data, method for evaluating measurement data using standard values
MX2017004127A (en) 2014-09-30 2017-10-24 Genetic Tech Limited Methods for assessing risk of developing breast cancer.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582788A (en) * 1982-01-22 1986-04-15 Cetus Corporation HLA typing method and cDNA probes used therein
US5075217A (en) * 1989-04-21 1991-12-24 Marshfield Clinic Length polymorphisms in (dC-dA)n ·(dG-dT)n sequences
US5840746A (en) * 1993-06-24 1998-11-24 Merck Frosst Canada, Inc. Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
WO2000033161A2 (en) 2000-06-08
WO2000033161A3 (en) 2000-11-02
MXPA01005513A (en) 2003-07-14
CA2350069A1 (en) 2000-06-08
WO2000033161A9 (en) 2001-04-19
JP2003501005A (en) 2003-01-14
EP1155361A2 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
AU5526399A (en) Improvements in or relating to the treatment of lesions
AU6712500A (en) Improvements in or relating to sterilising preparations
AU2846699A (en) Improvements in or relating to enclosures
GB9912413D0 (en) Compounds useful in therapy
AU6303800A (en) Improvements in or relating to polymers
AU3267199A (en) Improvements in or relating to headwear
GB9912410D0 (en) Compounds useful in therapy
AU2196401A (en) Improvements in or relating to internet access
AU3108200A (en) Methods to reduce variance in treatment studies using genotyping
AU5914600A (en) Juice enriched in beneficial compounds
GB9912416D0 (en) Compounds useful in therapy
GB9912415D0 (en) Compounds useful in therapy
AU6454300A (en) Improvements in and relating to electric lights
AU4808199A (en) Improvements to edging
AU3617799A (en) Improvements in or relating to contrast agents
GB9901052D0 (en) Improvements in and relating to tools
AU5434999A (en) Improvements in or relating to wheels
AU3446600A (en) Improvements in and relating to footwear
AU747073C (en) Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of medicament for the treatment of pain
AU3181795A (en) Improvements in or relating to connectors
AU3808800A (en) Compounds for use in therapy
AU1577900A (en) Improvements in or relating to pipes
AU5582899A (en) Formamides as therapeutic agents
AU7026000A (en) Improvements in or relating to ultrasound devices
AU2440295A (en) Improvements in or relating to earth-working tools

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase